ALB Stock Analysis
NYQ · Basic Materials · Specialty Chemicals
$107.01
-2.72 (-2.48%)
ALB Interactive Price Chart & Trading Signals
ALB Stock Snapshot — Valuation, Risk & Technical Signals
ALB Key Fundamentals, Analyst Targets & Company Profile
Key Financial Ratios
Market Cap
$12.63B
P/E Ratio
396.33
Forward P/E
9.47
PEG Ratio
0.79
P/B Ratio
1.57
EPS
$0.27
Dividend Yield
1.49%
52W Range
$79.30 – $221.00
Beta
1.33
Volume
0.8M
ROE
2.6%
Profit Margin
3.8%
Revenue Growth
31.1%
Gross Margin
24.0%
EV/EBITDA
10.66
Analyst Target
$171.56
The trailing price-to-earnings ratio stands at 396.3x. Forward P/E of 9.5x implies earnings expansion expected. Price-to-book is 1.57x. EV/EBITDA sits at 10.66x. Market capitalization is $12.63B. Revenue is growing at 31.1% on a trailing basis. Profit margins are 3.8%. Return on equity is 2.6%. Beta of 1.33 indicates elevated market sensitivity.
Analyst Consensus
Recommendation
Buy
Low Target
$83.28
Mean Target
$171.56
High Target
$225.00
Based on 20 analysts
About ALB
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
ALB Deep Dive Analysis
Bottom Line
Verdict
OvervaluedBest for
Growth-oriented investorsWatch out for
Premium valuation, High volatilityNon-zero inputs
4/5Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.
Albemarle Corporation (ALB) trades above our multi-model fair value estimate of $60.68 by approximately 43.3%. Trailing P/E: 396.3x. Profitability signals include profit margin of 3.8% and return on equity of 2.6%. Recent growth metrics show revenue growth of 31.1%. Risk profile: elevated market beta of 1.33. Consensus: buy.
Valuation, Growth & Risk
Valuation
Overvalued
P/E 396.3x
Price is above what fundamentals suggest.
Growth
Expanding
Rev 31.1%
Revenue is outpacing the market.
Risk
Elevated
Beta 1.33
Expect bigger swings than the market.
Valuation Snapshot
Albemarle Corporation (ALB) trades above our multi-model fair value estimate of $60.68 by approximately 43.3%. The trailing price-to-earnings ratio stands at 396.3x. Forward P/E of 9.5x suggests earnings compression ahead. Price-to-sales is 2.1x. Price-to-book is 1.6x. EV/EBITDA sits at 10.7x. Market capitalization is $12.63B.
Why it matters: Paying a premium works only if the company keeps growing faster than expected.
Growth & Profitability
Revenue is growing at 31.1% on a trailing basis. Profit margins are 3.8%. Return on equity is 2.6%. Return on assets is 3.2%.
Why it matters: Growing revenue with healthy margins usually means the business is gaining market share or pricing power.
Risk Profile
Beta of 1.33 indicates elevated market sensitivity. Net debt position is $367.25M.
Why it matters: A riskier stock can fall more in a downturn. Make sure your portfolio can handle the volatility.
Analyst Context
Analyst consensus target of $171.56 implies 60.3% upside. Target range spans $83.28 to $225.00. 20 analysts cover the stock. Consensus recommendation: buy.
Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.
Investor Fit
Premium valuation is supported by above-average growth, potentially fitting growth-oriented strategies. Free cash flow yield of 5.5% is attractive for cash-flow-focused investors.
Takeaway: Match the stock's risk-reward profile with your own goals and time horizon. No single metric tells the whole story.
Data Methodology & Sources
Market Data (Facts)
- Price, volume, and market cap: Yahoo Finance (may be delayed)
- P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
- Analyst estimates: Yahoo Finance (coverage and update times vary)
- Insider transactions: Yahoo Finance (reporting may be delayed)
QuantSoar Model (Derived)
- Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
- Margin of Safety = (Fair Value − Displayed Price) / Displayed Price × 100
- Composite Score: 40% Value + 30% Momentum + 30% Risk
- Verdict Gauge: Base 50 + Valuation (up to ±25) + Whale sentiment (up to ±10) + Insider buying (+5) + Macro risk (up to ±10) + Technical signal (up to ±10). Analyst consensus is separate.
Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.
ALB Overvalued
Albemarle Corporation (ALB) trades above our multi-model fair value estimate of $60.68 by approximately 43.3%.
Frequently Asked Questions
ValuationIs ALB stock overvalued right now?
ValuationWhat is ALB fair value based on current fundamentals?
RiskHow risky is ALB compared with other stocks?
GrowthIs ALB still growing?
AnalystWhat do analysts think about ALB?
DividendDoes ALB pay a dividend?
CatalystWhat could change the investment case for ALB?
Related Stocks
About the Author
Phasakorn Traklang (Peach) — Founder
Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.
Connect on LinkedInInvestment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC
Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.